Skip to main content
Advertisement
  • Other Publications
    • EMBO Press
    • EMBO Molecular Medicine (Home)
    • The EMBO Journal
    • EMBO reports
    • Molecular Systems Biology
    • Life Science Alliance
Login

   

Search

Advanced Search

Journal

  • Home
  • Latest Online
  • Current Issue
  • Archive
  • Article Collections
  • Subject Collections

Authors & Referees

  • Submit
  • Author Guidelines
  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Referee Guidelines
  • Bibliometrics
  • Open Access

Info

  • E-Mail Editorial Office
  • Alerts
  • RSS Feeds
  • Reprints & Permissions
  • Advertise & Sponsor
  • Media Partners
  • News & Press
  • Customer Service
  • Home
  • Latest Online

Open Access

Review

Delivery is key: lessons learnt from developing splice‐switching antisense therapies

Caroline Godfrey, Lourdes R Desviat, Bård Smedsrød, France Piétri‐Rouxel, Michela A Denti, Petra Disterer, Stéphanie Lorain, Gisela Nogales‐Gadea, Valentina Sardone, Rayan Anwar, Samir EL Andaloussi, Taavi Lehto, Bernard Khoo, Camilla Brolin, Willeke MC van Roon‐Mom, Aurélie Goyenvalle, Annemieke Aartsma‐Rus, View ORCID ProfileVirginia Arechavala‐Gomeza
DOI 10.15252/emmm.201607199 | Published online 13.03.2017
EMBO Molecular Medicine (2017) e201607199
Caroline Godfrey
Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lourdes R Desviat
Centro de Biología Molecular Severo Ochoa UAM‐CSIC, CIBERER, IdiPaz, Universidad Autónoma de Madrid, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bård Smedsrød
Department of Medical Biology, University of Tromsø, Tromsø, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
France Piétri‐Rouxel
UPMC, INSERM, UMRS 974, CNRS FRE 3617, Institut de Myologie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michela A Denti
Centre for Integrative Biology, University of Trento, Trento, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petra Disterer
Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stéphanie Lorain
UPMC, INSERM, UMRS 974, CNRS FRE 3617, Institut de Myologie, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gisela Nogales‐Gadea
Grup d'Investigació en Malalties Neuromusculars i Neuropediatriques, Institut d' Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valentina Sardone
Dubowitz Neuromuscular Centre and Developmental Neuroscience Programme, Institute of Child Health, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rayan Anwar
Drug Discovery Informatics Lab, Qasemi‐Research Center, Al‐Qasemi Academic College, Baka El‐Garbiah, IsraelDrug Discovery and Development Laboratory, Institute of Applied Research, Galilee Society, Shefa‐Amr, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samir EL Andaloussi
Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UKDepartment of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taavi Lehto
Department of Laboratory Medicine, Karolinska Institute, Stockholm, SwedenInstitute of Technology, University of Tartu, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernard Khoo
Centre for Neuroendocrinology, Division of Medicine, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Camilla Brolin
Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Willeke MC van Roon‐Mom
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurélie Goyenvalle
INSERM U1179, UFR des sciences de la santé, Université Versailles Saint Quentin, Montigny‐le‐Bretonneux, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annemieke Aartsma‐Rus
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virginia Arechavala‐Gomeza
Neuromuscular Disorders Group, BioCruces Health Research Institute, Barakaldo Bizkaia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. Caroline Godfrey1,
  2. Lourdes R Desviat2,
  3. Bård Smedsrød3,
  4. France Piétri‐Rouxel4,
  5. Michela A Denti5,
  6. Petra Disterer6,
  7. Stéphanie Lorain4,
  8. Gisela Nogales‐Gadea7,
  9. Valentina Sardone8,
  10. Rayan Anwar9,10,
  11. Samir EL Andaloussi1,11,
  12. Taavi Lehto11,12,
  13. Bernard Khoo13,
  14. Camilla Brolin14,
  15. Willeke MC van Roon‐Mom15,
  16. Aurélie Goyenvalle16,
  17. Annemieke Aartsma‐Rus15 and
  18. Virginia Arechavala‐Gomeza (virginia.arechavalagomeza{at}osakidetza.eus)*,17
  1. 1Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK
  2. 2Centro de Biología Molecular Severo Ochoa UAM‐CSIC, CIBERER, IdiPaz, Universidad Autónoma de Madrid, Madrid, Spain
  3. 3Department of Medical Biology, University of Tromsø, Tromsø, Norway
  4. 4UPMC, INSERM, UMRS 974, CNRS FRE 3617, Institut de Myologie, Paris, France
  5. 5Centre for Integrative Biology, University of Trento, Trento, Italy
  6. 6Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK
  7. 7Grup d'Investigació en Malalties Neuromusculars i Neuropediatriques, Institut d' Investigació en Ciències de la Salut Germans Trias i Pujol, Badalona Barcelona, Spain
  8. 8Dubowitz Neuromuscular Centre and Developmental Neuroscience Programme, Institute of Child Health, University College London, London, UK
  9. 9Drug Discovery Informatics Lab, Qasemi‐Research Center, Al‐Qasemi Academic College, Baka El‐Garbiah, Israel
  10. 10Drug Discovery and Development Laboratory, Institute of Applied Research, Galilee Society, Shefa‐Amr, Israel
  11. 11Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
  12. 12Institute of Technology, University of Tartu, Tartu, Estonia
  13. 13Centre for Neuroendocrinology, Division of Medicine, University College London, London, UK
  14. 14Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark
  15. 15Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
  16. 16INSERM U1179, UFR des sciences de la santé, Université Versailles Saint Quentin, Montigny‐le‐Bretonneux, France
  17. 17Neuromuscular Disorders Group, BioCruces Health Research Institute, Barakaldo Bizkaia, Spain
  1. ↵*Corresponding author. Tel: +34 946007967; E‐mail: virginia.arechavalagomeza{at}osakidetza.eus
View Abstract
  • Article
  • Figures & Data
  • Transparent Process
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. FDA‐approved antisense drugs (including nusinersen, which will be seeking accelerated approval soon)

     

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2. Barriers in AON delivery

     

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3. Strategies for improving delivery

     

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4. Stages in pre‐clinical AON development

     

Next Article in this Issue
Back to top

  • PDF
  • Share
  • Export
  • Print
Loading

PDF

In this Issue
Volume 10, Issue 4
01 April 2018 | pp -
EMBO Molecular Medicine: 10 (4)
About the cover
Alert me when this article is cited
Alert me if a correction is posted

Article

  • Article
    • Abstract
    • Introduction
    • Delivery hurdles and how to make the most of them
    • AON uptake mechanisms
    • Model systems used for pre‐clinical development of AONs
    • Concluding remarks
    • Conflict of interest
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Transparent Process

Related Content

More Reviews

  • Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease
    Fredrik EO Holmberg, Jakob B Seidelin, Xiaolei Yin, Benjamin E Mead, Zhixiang Tong, Yuan Li, Jeffrey M Karp, Ole H Nielsen
    EMBO Molecular Medicine 9: 558-570
  • The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non‐coding RNA and synonymous mutations
    Sven Diederichs, Lorenz Bartsch, Julia C Berkmann, Karin Fröse, Jana Heitmann, Caroline Hoppe, Deetje Iggena, Danny Jazmati, Philipp Karschnia, Miriam Linsenmeier, Thomas Maulhardt, Lino Möhrmann, Johannes Morstein, Stella V Paffenholz, Paula Röpenack, Timo Rückert, Ludger Sandig, Maximilian Schell, Anna Steinmann, Gjendine Voss, Jacqueline Wasmuth, Maria E Weinberger, Ramona Wullenkord
    EMBO Molecular Medicine 8: 442-457
More Review

Related Articles

Cited By...

Request Permissions

Subject Areas

  • Pharmacology & Drug Discovery

Journal

  • Latest Online
  • Current Issue
  • Archive
  • Focus Pages
  • Bibliometrics
  • E-Mail Editorial Office

Authors & References

  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Author Guidelines
  • Referee Guidelines
  • Open Access
  • Submit

Info

  • Alerts
  • RSS Feeds
  • Reprints & Permissions
  • Advertise & Sponsor
  • News & Press
  • Customer Service

EMBO

  • Funding & Awards
  • Events
  • Science Policy
  • Members
  • About EMBO

Online ISSN  1757-4684

Copyright© 2018 EMBO

This website is best viewed using the latest versions of all modern web browsers. Older browsers may not display correctly.